12-week open label treatment trial of divalproex sodium extended release (Depakote ER) in 10
patients with a diagnosis of autism. Our objective is to determine how well these patients
can tolerate the prescribed doses and what added benefits can be attributed to divalproex
sodium ER.
Phase:
Phase 4
Details
Lead Sponsor:
Icahn School of Medicine at Mount Sinai Montefiore Medical Center